The 6-hydroxydopamine Rat Model of Parkinson's Disease

J Vis Exp. 2021 Oct 27:(176). doi: 10.3791/62923.

Abstract

Motor symptoms of Parkinson's disease (PD)-bradykinesia, akinesia, and tremor at rest-are consequences of the neurodegeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) and dopaminergic striatal deficit. Animal models have been widely used to simulate human pathology in the laboratory. Rodents are the most used animal models for PD due to their ease of handling and maintenance. Moreover, the anatomy and molecular, cellular, and pharmacological mechanisms of PD are similar in rodents and humans. The infusion of the neurotoxin, 6-hydroxydopamine (6-OHDA), into a medial forebrain bundle (MFB) of rats reproduces the severe destruction of dopaminergic neurons and simulates PD symptoms. This protocol demonstrates how to perform the unilateral microinjection of 6-OHDA in the MFB in a rat model of PD and shows the motor deficits induced by 6-OHDA and predicted dopaminergic lesions through the stepping test. The 6-OHDA causes significant impairment in the number of steps performed with the contralateral forelimb.

Publication types

  • Research Support, Non-U.S. Gov't
  • Video-Audio Media

MeSH terms

  • Animals
  • Disease Models, Animal
  • Dopamine
  • Dopaminergic Neurons / pathology
  • Medial Forebrain Bundle
  • Oxidopamine
  • Parkinson Disease* / etiology
  • Parkinson Disease* / pathology
  • Rats
  • Substantia Nigra / pathology

Substances

  • Oxidopamine
  • Dopamine